Cytori Therapeutics, Inc. (CYTX) was a big mover last session, as its shares rose over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company, as the stock is now down a little over 27% in the past one-month time frame.
In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. So make sure to keep an eye on this stock going forward to see if Friday’s jump can turn into more strength down the road.
Cytori Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the biomedical/gene industry include Gilead Sciences Inc. (GILD), Cambrex Corporation. (CBM) and China Biologic Products, Inc. (CBPO). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment